Amprius Technologies, Inc. Form 8-K Summary
Business Context and Reporting Period
The Form 8-K was filed on September 14, 2022, regarding the completion of the business combination between Kensington Capital Acquisition Corp. IV and Amprius Technologies Operating, Inc. The combined company operates as Amprius Technologies, Inc. and trades on the New York Stock Exchange under “AMPX”; its redeemable warrants trade under “AMPX.W.”
The transaction was described in the proxy statement/prospectus filed September 1, 2022 and approved by shareholders at a special meeting on September 13, 2022. The filing reports a corporate transaction rather than a periodic financial-results update.
Financial and Operating Metrics
- The filing does not provide revenue, net income, cash flow, margins, debt, liquidity, balance-sheet amounts, or other current-period financial metrics.
- The filing does not provide a comparable prior-period financial analysis.
- The filing does not state the amount of cash raised, transaction expenses, redemptions, or pro forma capitalization in the text provided.
Material Changes Versus the Prior Comparable Period
- The material event is the completion of the business combination and the change in the registrant’s name from Kensington Capital Acquisition Corp. IV to Amprius Technologies, Inc.
- The filing does not present operating or financial changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
- No new revenue or earnings guidance is provided.
- No management outlook, risk-factor update, contingency, or unusual accounting item is described in the filing text.
- The transaction itself is the principal unusual event reported. Additional transaction details were referenced in the proxy statement/prospectus and the attached September 14, 2022 press release, but their substantive contents are not included in the provided text.
- The company identifies as an emerging growth company.
Investor Verification Items
- Review the September 14, 2022 press release filed as Exhibit 99.1 for transaction terms and management commentary.
- Review the September 1, 2022 proxy statement/prospectus for merger consideration, financing, redemption levels, transaction expenses, pro forma capitalization, and projected operating results.
- Verify the company’s post-closing cash balance, debt, liquidity runway, and any financing commitments in subsequent periodic filings.
- Confirm the timing and terms of the company’s transition to trading under AMPX and AMPX.W.